Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2377–2400 of 2,513 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Ewing's Sarcoma, Rhabdomyosarcoma
Interventions: therapeutic autologous dendritic cells, indinavir sulfate, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 5 Years to 35 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV, HIV Linkage to Care, HIV Testing, HIV Treatment
Interventions: COAST-AL; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 13 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Bipolar Disorder, Rapid Cycling Bipolar Disorder
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2001
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Delayed Sleep Phase Syndrome
Interventions: Melatonin 0.5 MG, Dim Light Melatonin Onset (salivary); Drug · Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 65 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Atrial Fibrillation, Catheter Ablation
Interventions: Protamine Sulfate; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Opioid Use Disorder
Interventions: RMIST; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Healthy
Interventions: Nirogacestat, Nirogacestat and Famotidine, Nirogacestat and Rabeprazole; Drug
Lead sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Diet, Healthy, Weight Change, Body, Dyslipidemias, Blood Pressure
Interventions: Fasting; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Streptococcal Pharyngitis, Group A Streptococcal Infection
Interventions: qPCR; Diagnostic Test
Lead sponsor: SalivIQ Diagnostics, Inc.; Industry
Eligibility: 3 Years and older
Enrollment: 668 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Baton Rouge, Louisiana • North Andover, Massachusetts • Dallas, Texas

Conditions: SARS-CoV-2, Covid19
Interventions: POC CoviDx™ Rapid Antigen Test; Device
Lead sponsor: Lumos Diagnostics; Industry
Eligibility: 1 Year and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: Hialeah, Florida • West Palm Beach, Florida

Conditions: Intracerebral Hemorrhage
Interventions: Arctic Sun cooling device, Standard of Care; Device · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Substance Abuse, Intravenous
Interventions: Abstinence-contingent wage supplements, Individual Placement and Support (IPS) supported employment; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Postpartum Hemorrhage, Postsurgical Bleeding, Abdominal Ultrasound, FAST Scan, Non-invasive Hemoglobin Measurement
Interventions: FAST scan and non-invasive hemoglobin measurement; Device
Lead sponsor: Northwestern University; Other
Eligibility: 12 Years to 60 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Childhood Cancer
Interventions: JUMP; Behavioral
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 6 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Schizophrenia, Nicotine Dependence
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Interstitial Cystitis, Bladder Pain Syndrome
Interventions: Polymerase Chain Reaction and Next-Generation DNA Sequencing; Diagnostic Test
Lead sponsor: MicroGenDX; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: Los Angeles, California • San Diego, California • Camden, New Jersey + 1 more

Conditions: Biological Specimens
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Blood Pressure Control
Interventions: ACT-BP Intervention; Other
Lead sponsor: Elizabeth Pfoh; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Cleveland, Ohio • Mayfield Heights, Ohio

Conditions: Diabetes, Hypertension, HIV
Interventions: HIV testing, General Health Screen; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Sepsis
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: HIV Infections, Hepatitis B Infections, Hepatitis C Infections
Interventions: Multiplo HBc/HIV/HCV and Reveal HBsAg; Device
Lead sponsor: MedMira Laboratories Inc.; Industry
Eligibility: 13 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 4
States / cities: Los Angeles, California • Miami, Florida • Minneapolis, Minnesota + 1 more

Conditions: Methamphetamine Abuse, Substance Use Disorders, Stimulant Dependence, Methamphetamine-dependence, Stimulant Use, Transcranial Magnetic Stimulation
Interventions: Real Repetitive transcranial magnetic stimulation, Sham Repetitive transcranial magnetic stimulation, Methamphetamine visual cues, Neutral visual cues; Device · Behavioral
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Intubation Complication
Interventions: Etomidate, Ketamine; Drug
Lead sponsor: South East Area Health Education Center, Wilmington, NC; Other
Eligibility: 18 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Blood Pressure, Medication Adherence
Interventions: Electronic Health Record (EHR) Enabled Teamlets; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 1,842 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

Evaluation of Patients With Rapid Cycling Bipolar Disorder (RCBD)

The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder

Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation

Remote Methadone Ingestion Surveillance Trial (RMIST)

Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat

Effects of a Daily Time-Restricted Feeding Protocol on Diet Quality

A Multicenter Evaluation of SalivIQ™ Strep A for Detecting Group A Streptococcus From Saliva and Throat Swabs in Patients With Acute Pharyngitis

Clinical Evaluation of a Point-of-Care (POC), COVID-19 Rapid Antigen Test (CoviDx™)

Systemic Normothermia in Intracerebral Hemorrhage (ICH)

The Long-Term Treatment of Drug Addiction and Unemployment

Abdominal Ultrasound Assessment in the Post-cesarean Patient

Examining a Training Program for for Acute Lymphoblastic Leukemia Childhood Cancer Survivors

Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia

Assessment of Urinary Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) Technology in the Evaluation and Management of Females With Chronic Bladder Pain and Cystitis-like Symptoms

Rapid Acquisition of Pre- and Post-Incident Disaster Data

Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes

Project Wellness: Increasing HIV Testing Among West African Immigrants

Point of Care Ultrasound to Predict Intensive Care Unit Admission of Patients Presenting With Sepsis to the Emergency Department

Rapid Diagnostics for HIV and Hepatitis

rTMS for Craving in Methamphetamine Use Disorder

Evaluating the Hemodynamic Effects of Ketamine Versus Etomidate During Rapid Sequence Intubation

Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care